- IQVIA (IQV, Financial) named 'front-runner generative AI leader' by Everest Group in life sciences.
- Recognized for strategic integrations of generative AI in clinical research and commercialization.
- IQVIA AI Assistant awarded PM360 Innovation Award for AI in healthcare and life sciences.
In a recent report by Everest Group, IQVIA (IQV), a prominent provider of clinical research services and healthcare intelligence, was recognized as a “front-runner generative AI leader” within the life sciences industry. This accolade establishes IQVIA as the only clinical research organization to receive the highest ranking among fifteen companies, emphasizing its pioneering role in operationalizing generative AI capabilities.
IQVIA's innovative use of AI solutions spans various stages of research and development, enhancing patient journey analytics and optimizing clinical trial designs. Their Healthcare-grade AI® solutions are integral in refining product commercialization strategies and providing deep insights into market access, paving the way for improved healthcare outcomes.
The company stands out in the CRO industry, being the only organization with a dedicated technology business unit recognized as a front-runner. IQVIA's emphasis on responsible AI governance and operational excellence underscores its leadership in advancing AI technologies in healthcare and life sciences.
Earlier this year, the IQVIA AI Assistant was honored with the PM360 Innovation Award in the AI Category, further solidifying the company's commitment to harnessing AI to revolutionize insight generation across the industry.
